OBJECTIVE Previous in vitro studies have demonstrated significant 11-beta h
ydroxysteroid dehydrogenase (11 beta-HSD) oxo-reductase activity in viscera
l, but not subcutaneous adipose stromal cells. We have conducted an in vivo
study of the cortisol-cortisone shuttle in subcutaneous abdominal adipose
tissue.
DESIGN We measured arteriovenous (A-V) differences in serum cortisol and co
rtisone across subcutaneous abdominal adipose tissue and forearm muscle in
a heterogeneous group of subjects.
PATIENTS We studied 34 subjects (male:female = 12:22), age median (interqua
rtile range) 45 (19-65) years, body mass index 32.7 (20.4-77.1) kg m(-2), t
otal body fat 34.4 (5.6-119.1) kg,
MEASUREMENTS Serum cortisol and cortisone were measured in serum samples fr
om a radial artery, superficial epigastric vein and deep forearm vein. Abdo
minal adipose and forearm blood flow rates were measured by (133)Xenon wash
out and plethysmography, respectively.
RESULTS For cortisone, there was significant (P < 0.001) clearance by adipo
se tissue, with an A-V difference of 4 (1-7) nmol/l. For cortisol there was
a trend for arterial concentrations (203 (142-292) nmol/l) to be lower tha
n venous (225 (152-263) nmol/l), but this was not significant. The adipose
tissue cortisone clearance rate correlated with total body fat (r = 0.35, P
= 0.05).
CONCLUSIONS We have demonstrated 11 beta-HSD oxo-reductase activity in subc
utaneous abdominal adipose tissue, which may be increased in obesity.